Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction

Overview of attention for article published in Archives of Gynecology and Obstetrics, July 2000

Altmetric Badge

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 84 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Oligopeptide lyophilisate, their preparation and use

Grant US-7605121-B2

United States of America

Preparation and use of oligopeptide lyophilisate for gonad protection

Grant US-6867191-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.